nodes	percent_of_prediction	percent_of_DWPC	metapath
Perindopril—ACE—systemic scleroderma	0.246	1	CbGaD
Perindopril—ACE—Lisinopril—systemic scleroderma	0.106	0.364	CbGbCtD
Perindopril—Enalapril—Captopril—systemic scleroderma	0.104	0.296	CrCrCtD
Perindopril—ACE—Captopril—systemic scleroderma	0.0794	0.272	CbGbCtD
Perindopril—SLC15A1—Lisinopril—systemic scleroderma	0.0425	0.146	CbGbCtD
Perindopril—Moexipril—Lisinopril—systemic scleroderma	0.0425	0.12	CrCrCtD
Perindopril—Cilazapril—Lisinopril—systemic scleroderma	0.0367	0.104	CrCrCtD
Perindopril—Spirapril—Lisinopril—systemic scleroderma	0.0367	0.104	CrCrCtD
Perindopril—Trandolapril—Lisinopril—systemic scleroderma	0.0345	0.0976	CrCrCtD
Perindopril—Ramipril—Lisinopril—systemic scleroderma	0.0345	0.0976	CrCrCtD
Perindopril—Enalapril—Lisinopril—systemic scleroderma	0.0345	0.0976	CrCrCtD
Perindopril—SLC15A1—Captopril—systemic scleroderma	0.0318	0.109	CbGbCtD
Perindopril—Quinapril—Lisinopril—systemic scleroderma	0.0292	0.0827	CrCrCtD
Perindopril—ABCB1—Lisinopril—systemic scleroderma	0.0104	0.0358	CbGbCtD
Perindopril—ABCB1—Captopril—systemic scleroderma	0.00782	0.0268	CbGbCtD
Perindopril—ABCB1—Mycophenolate mofetil—systemic scleroderma	0.00616	0.0211	CbGbCtD
Perindopril—ABCB1—Prednisone—systemic scleroderma	0.00492	0.0169	CbGbCtD
Perindopril—ACE—forelimb zeugopod—systemic scleroderma	0.00473	0.22	CbGeAlD
Perindopril—ACE—pulmonary artery—systemic scleroderma	0.00354	0.165	CbGeAlD
Perindopril—ACE—skeletal joint—systemic scleroderma	0.00313	0.146	CbGeAlD
Perindopril—ABCB1—Methotrexate—systemic scleroderma	0.00247	0.00846	CbGbCtD
Perindopril—ACE—umbilical vein—systemic scleroderma	0.00234	0.109	CbGeAlD
Perindopril—ACE—artery—systemic scleroderma	0.00131	0.061	CbGeAlD
Perindopril—ACE—endothelium—systemic scleroderma	0.00111	0.0515	CbGeAlD
Perindopril—ACE—blood vessel—systemic scleroderma	0.00102	0.0475	CbGeAlD
Perindopril—SLC15A1—digestive system—systemic scleroderma	0.000527	0.0245	CbGeAlD
Perindopril—ACE—connective tissue—systemic scleroderma	0.000524	0.0244	CbGeAlD
Perindopril—ACE—smooth muscle tissue—systemic scleroderma	0.000479	0.0223	CbGeAlD
Perindopril—Spirapril—ACE—systemic scleroderma	0.000401	0.163	CrCbGaD
Perindopril—Moexipril—ACE—systemic scleroderma	0.000385	0.157	CrCbGaD
Perindopril—ACE—digestive system—systemic scleroderma	0.000378	0.0176	CbGeAlD
Perindopril—ABCB1—blood vessel—systemic scleroderma	0.000359	0.0167	CbGeAlD
Perindopril—Quinapril—ACE—systemic scleroderma	0.000358	0.146	CrCbGaD
Perindopril—Cilazapril—ACE—systemic scleroderma	0.000358	0.146	CrCbGaD
Perindopril—BCHE—smooth muscle tissue—systemic scleroderma	0.000354	0.0165	CbGeAlD
Perindopril—BCHE—skin of body—systemic scleroderma	0.000349	0.0162	CbGeAlD
Perindopril—Ramipril—ACE—systemic scleroderma	0.000347	0.141	CrCbGaD
Perindopril—Trandolapril—ACE—systemic scleroderma	0.000347	0.141	CrCbGaD
Perindopril—ACE—lung—systemic scleroderma	0.000316	0.0147	CbGeAlD
Perindopril—BCHE—digestive system—systemic scleroderma	0.000279	0.013	CbGeAlD
Perindopril—SLC15A2—lung—systemic scleroderma	0.000275	0.0128	CbGeAlD
Perindopril—Enalapril—ACE—systemic scleroderma	0.000263	0.107	CrCbGaD
Perindopril—BCHE—lung—systemic scleroderma	0.000233	0.0109	CbGeAlD
Perindopril—ABCB1—digestive system—systemic scleroderma	0.000133	0.00619	CbGeAlD
Perindopril—ABCB1—lung—systemic scleroderma	0.000111	0.00517	CbGeAlD
Perindopril—Palpitations—Mycophenolate mofetil—systemic scleroderma	4.48e-05	0.000524	CcSEcCtD
Perindopril—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	4.46e-05	0.000521	CcSEcCtD
Perindopril—Cough—Mycophenolate mofetil—systemic scleroderma	4.42e-05	0.000518	CcSEcCtD
Perindopril—Hypotension—Lisinopril—systemic scleroderma	4.41e-05	0.000516	CcSEcCtD
Perindopril—Dizziness—Captopril—systemic scleroderma	4.41e-05	0.000516	CcSEcCtD
Perindopril—Hypertension—Mycophenolate mofetil—systemic scleroderma	4.38e-05	0.000512	CcSEcCtD
Perindopril—Urticaria—Leflunomide—systemic scleroderma	4.37e-05	0.000511	CcSEcCtD
Perindopril—Abdominal pain—Leflunomide—systemic scleroderma	4.35e-05	0.000508	CcSEcCtD
Perindopril—Body temperature increased—Leflunomide—systemic scleroderma	4.35e-05	0.000508	CcSEcCtD
Perindopril—Acute coronary syndrome—Prednisone—systemic scleroderma	4.34e-05	0.000507	CcSEcCtD
Perindopril—Feeling abnormal—Mycophenolic acid—systemic scleroderma	4.32e-05	0.000506	CcSEcCtD
Perindopril—Arthralgia—Mycophenolate mofetil—systemic scleroderma	4.32e-05	0.000505	CcSEcCtD
Perindopril—Chest pain—Mycophenolate mofetil—systemic scleroderma	4.32e-05	0.000505	CcSEcCtD
Perindopril—Myalgia—Mycophenolate mofetil—systemic scleroderma	4.32e-05	0.000505	CcSEcCtD
Perindopril—Myocardial infarction—Prednisone—systemic scleroderma	4.31e-05	0.000504	CcSEcCtD
Perindopril—Breast disorder—Methotrexate—systemic scleroderma	4.31e-05	0.000504	CcSEcCtD
Perindopril—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	4.3e-05	0.000503	CcSEcCtD
Perindopril—Anxiety—Mycophenolate mofetil—systemic scleroderma	4.3e-05	0.000503	CcSEcCtD
Perindopril—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	4.29e-05	0.000502	CcSEcCtD
Perindopril—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	4.29e-05	0.000502	CcSEcCtD
Perindopril—Insomnia—Lisinopril—systemic scleroderma	4.27e-05	0.0005	CcSEcCtD
Perindopril—Discomfort—Mycophenolate mofetil—systemic scleroderma	4.27e-05	0.000499	CcSEcCtD
Perindopril—Paraesthesia—Lisinopril—systemic scleroderma	4.24e-05	0.000496	CcSEcCtD
Perindopril—Vomiting—Captopril—systemic scleroderma	4.24e-05	0.000496	CcSEcCtD
Perindopril—Dry mouth—Mycophenolate mofetil—systemic scleroderma	4.22e-05	0.000494	CcSEcCtD
Perindopril—Dyspnoea—Lisinopril—systemic scleroderma	4.21e-05	0.000493	CcSEcCtD
Perindopril—Rash—Captopril—systemic scleroderma	4.21e-05	0.000492	CcSEcCtD
Perindopril—Dermatitis—Captopril—systemic scleroderma	4.2e-05	0.000492	CcSEcCtD
Perindopril—Somnolence—Lisinopril—systemic scleroderma	4.2e-05	0.000491	CcSEcCtD
Perindopril—Headache—Captopril—systemic scleroderma	4.18e-05	0.000489	CcSEcCtD
Perindopril—Confusional state—Mycophenolate mofetil—systemic scleroderma	4.17e-05	0.000488	CcSEcCtD
Perindopril—Dyspepsia—Lisinopril—systemic scleroderma	4.16e-05	0.000486	CcSEcCtD
Perindopril—Body temperature increased—Mycophenolic acid—systemic scleroderma	4.15e-05	0.000485	CcSEcCtD
Perindopril—Abdominal pain—Mycophenolic acid—systemic scleroderma	4.15e-05	0.000485	CcSEcCtD
Perindopril—Oedema—Mycophenolate mofetil—systemic scleroderma	4.14e-05	0.000484	CcSEcCtD
Perindopril—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	4.14e-05	0.000484	CcSEcCtD
Perindopril—Asthma—Methotrexate—systemic scleroderma	4.12e-05	0.000482	CcSEcCtD
Perindopril—Decreased appetite—Lisinopril—systemic scleroderma	4.11e-05	0.00048	CcSEcCtD
Perindopril—Eosinophilia—Methotrexate—systemic scleroderma	4.08e-05	0.000478	CcSEcCtD
Perindopril—Gastrointestinal disorder—Lisinopril—systemic scleroderma	4.08e-05	0.000477	CcSEcCtD
Perindopril—Fatigue—Lisinopril—systemic scleroderma	4.07e-05	0.000476	CcSEcCtD
Perindopril—Shock—Mycophenolate mofetil—systemic scleroderma	4.07e-05	0.000476	CcSEcCtD
Perindopril—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	4.06e-05	0.000475	CcSEcCtD
Perindopril—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	4.05e-05	0.000474	CcSEcCtD
Perindopril—Pancreatitis—Methotrexate—systemic scleroderma	4.04e-05	0.000473	CcSEcCtD
Perindopril—Constipation—Lisinopril—systemic scleroderma	4.04e-05	0.000473	CcSEcCtD
Perindopril—Pain—Lisinopril—systemic scleroderma	4.04e-05	0.000473	CcSEcCtD
Perindopril—Tachycardia—Mycophenolate mofetil—systemic scleroderma	4.04e-05	0.000473	CcSEcCtD
Perindopril—Skin disorder—Mycophenolate mofetil—systemic scleroderma	4.02e-05	0.00047	CcSEcCtD
Perindopril—Bradycardia—Prednisone—systemic scleroderma	4.02e-05	0.00047	CcSEcCtD
Perindopril—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	4e-05	0.000468	CcSEcCtD
Perindopril—Diarrhoea—Azathioprine—systemic scleroderma	3.98e-05	0.000466	CcSEcCtD
Perindopril—Haemoglobin—Prednisone—systemic scleroderma	3.97e-05	0.000464	CcSEcCtD
Perindopril—Nausea—Captopril—systemic scleroderma	3.96e-05	0.000463	CcSEcCtD
Perindopril—Haemorrhage—Prednisone—systemic scleroderma	3.95e-05	0.000462	CcSEcCtD
Perindopril—Anorexia—Mycophenolate mofetil—systemic scleroderma	3.94e-05	0.000461	CcSEcCtD
Perindopril—Asthenia—Leflunomide—systemic scleroderma	3.94e-05	0.000461	CcSEcCtD
Perindopril—Hallucination—Prednisone—systemic scleroderma	3.93e-05	0.00046	CcSEcCtD
Perindopril—Pancytopenia—Methotrexate—systemic scleroderma	3.92e-05	0.000458	CcSEcCtD
Perindopril—Feeling abnormal—Lisinopril—systemic scleroderma	3.89e-05	0.000455	CcSEcCtD
Perindopril—Pruritus—Leflunomide—systemic scleroderma	3.89e-05	0.000455	CcSEcCtD
Perindopril—Hypotension—Mycophenolate mofetil—systemic scleroderma	3.87e-05	0.000452	CcSEcCtD
Perindopril—Gastrointestinal pain—Lisinopril—systemic scleroderma	3.86e-05	0.000452	CcSEcCtD
Perindopril—Neutropenia—Methotrexate—systemic scleroderma	3.85e-05	0.000451	CcSEcCtD
Perindopril—Dizziness—Azathioprine—systemic scleroderma	3.85e-05	0.00045	CcSEcCtD
Perindopril—Upper respiratory tract infection—Methotrexate—systemic scleroderma	3.83e-05	0.000448	CcSEcCtD
Perindopril—Erectile dysfunction—Methotrexate—systemic scleroderma	3.8e-05	0.000444	CcSEcCtD
Perindopril—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	3.77e-05	0.000441	CcSEcCtD
Perindopril—Photosensitivity reaction—Methotrexate—systemic scleroderma	3.76e-05	0.00044	CcSEcCtD
Perindopril—Asthenia—Mycophenolic acid—systemic scleroderma	3.76e-05	0.00044	CcSEcCtD
Perindopril—Diarrhoea—Leflunomide—systemic scleroderma	3.76e-05	0.00044	CcSEcCtD
Perindopril—Urticaria—Lisinopril—systemic scleroderma	3.75e-05	0.000439	CcSEcCtD
Perindopril—Insomnia—Mycophenolate mofetil—systemic scleroderma	3.74e-05	0.000438	CcSEcCtD
Perindopril—Abdominal pain—Lisinopril—systemic scleroderma	3.73e-05	0.000437	CcSEcCtD
Perindopril—Body temperature increased—Lisinopril—systemic scleroderma	3.73e-05	0.000437	CcSEcCtD
Perindopril—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	3.72e-05	0.000435	CcSEcCtD
Perindopril—Pruritus—Mycophenolic acid—systemic scleroderma	3.71e-05	0.000434	CcSEcCtD
Perindopril—Vomiting—Azathioprine—systemic scleroderma	3.7e-05	0.000433	CcSEcCtD
Perindopril—Pneumonia—Methotrexate—systemic scleroderma	3.7e-05	0.000433	CcSEcCtD
Perindopril—Eye disorder—Prednisone—systemic scleroderma	3.69e-05	0.000432	CcSEcCtD
Perindopril—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	3.69e-05	0.000432	CcSEcCtD
Perindopril—Somnolence—Mycophenolate mofetil—systemic scleroderma	3.68e-05	0.00043	CcSEcCtD
Perindopril—Drowsiness—Methotrexate—systemic scleroderma	3.68e-05	0.00043	CcSEcCtD
Perindopril—Rash—Azathioprine—systemic scleroderma	3.67e-05	0.000429	CcSEcCtD
Perindopril—Dermatitis—Azathioprine—systemic scleroderma	3.67e-05	0.000429	CcSEcCtD
Perindopril—Flushing—Prednisone—systemic scleroderma	3.66e-05	0.000429	CcSEcCtD
Perindopril—Headache—Azathioprine—systemic scleroderma	3.65e-05	0.000427	CcSEcCtD
Perindopril—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	3.64e-05	0.000426	CcSEcCtD
Perindopril—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	3.64e-05	0.000426	CcSEcCtD
Perindopril—Dizziness—Leflunomide—systemic scleroderma	3.63e-05	0.000425	CcSEcCtD
Perindopril—Renal failure—Methotrexate—systemic scleroderma	3.61e-05	0.000423	CcSEcCtD
Perindopril—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	3.6e-05	0.000421	CcSEcCtD
Perindopril—Diarrhoea—Mycophenolic acid—systemic scleroderma	3.59e-05	0.00042	CcSEcCtD
Perindopril—Stomatitis—Methotrexate—systemic scleroderma	3.58e-05	0.000419	CcSEcCtD
Perindopril—Angiopathy—Prednisone—systemic scleroderma	3.58e-05	0.000419	CcSEcCtD
Perindopril—Conjunctivitis—Methotrexate—systemic scleroderma	3.57e-05	0.000418	CcSEcCtD
Perindopril—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	3.57e-05	0.000418	CcSEcCtD
Perindopril—Pain—Mycophenolate mofetil—systemic scleroderma	3.54e-05	0.000414	CcSEcCtD
Perindopril—Constipation—Mycophenolate mofetil—systemic scleroderma	3.54e-05	0.000414	CcSEcCtD
Perindopril—Arrhythmia—Prednisone—systemic scleroderma	3.53e-05	0.000413	CcSEcCtD
Perindopril—Sweating—Methotrexate—systemic scleroderma	3.52e-05	0.000412	CcSEcCtD
Perindopril—Haematuria—Methotrexate—systemic scleroderma	3.5e-05	0.00041	CcSEcCtD
Perindopril—Vomiting—Leflunomide—systemic scleroderma	3.49e-05	0.000409	CcSEcCtD
Perindopril—Alopecia—Prednisone—systemic scleroderma	3.49e-05	0.000408	CcSEcCtD
Perindopril—Hepatobiliary disease—Methotrexate—systemic scleroderma	3.48e-05	0.000407	CcSEcCtD
Perindopril—Dizziness—Mycophenolic acid—systemic scleroderma	3.47e-05	0.000406	CcSEcCtD
Perindopril—Epistaxis—Methotrexate—systemic scleroderma	3.47e-05	0.000406	CcSEcCtD
Perindopril—Rash—Leflunomide—systemic scleroderma	3.47e-05	0.000405	CcSEcCtD
Perindopril—Dermatitis—Leflunomide—systemic scleroderma	3.46e-05	0.000405	CcSEcCtD
Perindopril—Mental disorder—Prednisone—systemic scleroderma	3.46e-05	0.000405	CcSEcCtD
Perindopril—Nausea—Azathioprine—systemic scleroderma	3.46e-05	0.000404	CcSEcCtD
Perindopril—Headache—Leflunomide—systemic scleroderma	3.44e-05	0.000403	CcSEcCtD
Perindopril—Malnutrition—Prednisone—systemic scleroderma	3.44e-05	0.000402	CcSEcCtD
Perindopril—Erythema—Prednisone—systemic scleroderma	3.44e-05	0.000402	CcSEcCtD
Perindopril—Agranulocytosis—Methotrexate—systemic scleroderma	3.43e-05	0.000401	CcSEcCtD
Perindopril—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	3.41e-05	0.000399	CcSEcCtD
Perindopril—Asthenia—Lisinopril—systemic scleroderma	3.39e-05	0.000396	CcSEcCtD
Perindopril—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	3.38e-05	0.000396	CcSEcCtD
Perindopril—Pruritus—Lisinopril—systemic scleroderma	3.34e-05	0.000391	CcSEcCtD
Perindopril—Vomiting—Mycophenolic acid—systemic scleroderma	3.33e-05	0.00039	CcSEcCtD
Perindopril—Haemoglobin—Methotrexate—systemic scleroderma	3.32e-05	0.000388	CcSEcCtD
Perindopril—Rash—Mycophenolic acid—systemic scleroderma	3.31e-05	0.000387	CcSEcCtD
Perindopril—Dermatitis—Mycophenolic acid—systemic scleroderma	3.3e-05	0.000386	CcSEcCtD
Perindopril—Haemorrhage—Methotrexate—systemic scleroderma	3.3e-05	0.000386	CcSEcCtD
Perindopril—Hepatitis—Methotrexate—systemic scleroderma	3.3e-05	0.000386	CcSEcCtD
Perindopril—Urticaria—Mycophenolate mofetil—systemic scleroderma	3.29e-05	0.000385	CcSEcCtD
Perindopril—Headache—Mycophenolic acid—systemic scleroderma	3.29e-05	0.000384	CcSEcCtD
Perindopril—Pharyngitis—Methotrexate—systemic scleroderma	3.28e-05	0.000383	CcSEcCtD
Perindopril—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	3.27e-05	0.000383	CcSEcCtD
Perindopril—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	3.27e-05	0.000383	CcSEcCtD
Perindopril—Nausea—Leflunomide—systemic scleroderma	3.27e-05	0.000382	CcSEcCtD
Perindopril—Urinary tract disorder—Methotrexate—systemic scleroderma	3.26e-05	0.000381	CcSEcCtD
Perindopril—Urethral disorder—Methotrexate—systemic scleroderma	3.23e-05	0.000378	CcSEcCtD
Perindopril—Diarrhoea—Lisinopril—systemic scleroderma	3.23e-05	0.000378	CcSEcCtD
Perindopril—Ill-defined disorder—Prednisone—systemic scleroderma	3.19e-05	0.000373	CcSEcCtD
Perindopril—Visual impairment—Methotrexate—systemic scleroderma	3.18e-05	0.000372	CcSEcCtD
Perindopril—Anaemia—Prednisone—systemic scleroderma	3.18e-05	0.000372	CcSEcCtD
Perindopril—Agitation—Prednisone—systemic scleroderma	3.16e-05	0.00037	CcSEcCtD
Perindopril—Angioedema—Prednisone—systemic scleroderma	3.14e-05	0.000367	CcSEcCtD
Perindopril—Dizziness—Lisinopril—systemic scleroderma	3.12e-05	0.000365	CcSEcCtD
Perindopril—Erythema multiforme—Methotrexate—systemic scleroderma	3.12e-05	0.000365	CcSEcCtD
Perindopril—Nausea—Mycophenolic acid—systemic scleroderma	3.11e-05	0.000364	CcSEcCtD
Perindopril—Malaise—Prednisone—systemic scleroderma	3.1e-05	0.000363	CcSEcCtD
Perindopril—Vertigo—Prednisone—systemic scleroderma	3.09e-05	0.000361	CcSEcCtD
Perindopril—Eye disorder—Methotrexate—systemic scleroderma	3.08e-05	0.000361	CcSEcCtD
Perindopril—Syncope—Prednisone—systemic scleroderma	3.08e-05	0.000361	CcSEcCtD
Perindopril—Tinnitus—Methotrexate—systemic scleroderma	3.08e-05	0.00036	CcSEcCtD
Perindopril—Cardiac disorder—Methotrexate—systemic scleroderma	3.06e-05	0.000358	CcSEcCtD
Perindopril—Loss of consciousness—Prednisone—systemic scleroderma	3.02e-05	0.000353	CcSEcCtD
Perindopril—Vomiting—Lisinopril—systemic scleroderma	3e-05	0.000351	CcSEcCtD
Perindopril—Angiopathy—Methotrexate—systemic scleroderma	2.99e-05	0.00035	CcSEcCtD
Perindopril—Rash—Lisinopril—systemic scleroderma	2.98e-05	0.000348	CcSEcCtD
Perindopril—Dermatitis—Lisinopril—systemic scleroderma	2.98e-05	0.000348	CcSEcCtD
Perindopril—Mediastinal disorder—Methotrexate—systemic scleroderma	2.97e-05	0.000348	CcSEcCtD
Perindopril—Asthenia—Mycophenolate mofetil—systemic scleroderma	2.97e-05	0.000347	CcSEcCtD
Perindopril—Hypertension—Prednisone—systemic scleroderma	2.97e-05	0.000347	CcSEcCtD
Perindopril—Chills—Methotrexate—systemic scleroderma	2.96e-05	0.000346	CcSEcCtD
Perindopril—Headache—Lisinopril—systemic scleroderma	2.96e-05	0.000346	CcSEcCtD
Perindopril—Pruritus—Mycophenolate mofetil—systemic scleroderma	2.93e-05	0.000343	CcSEcCtD
Perindopril—Arthralgia—Prednisone—systemic scleroderma	2.93e-05	0.000342	CcSEcCtD
Perindopril—Myalgia—Prednisone—systemic scleroderma	2.93e-05	0.000342	CcSEcCtD
Perindopril—Anxiety—Prednisone—systemic scleroderma	2.92e-05	0.000341	CcSEcCtD
Perindopril—Alopecia—Methotrexate—systemic scleroderma	2.92e-05	0.000341	CcSEcCtD
Perindopril—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	2.91e-05	0.00034	CcSEcCtD
Perindopril—Discomfort—Prednisone—systemic scleroderma	2.89e-05	0.000338	CcSEcCtD
Perindopril—Mental disorder—Methotrexate—systemic scleroderma	2.89e-05	0.000338	CcSEcCtD
Perindopril—Erythema—Methotrexate—systemic scleroderma	2.87e-05	0.000336	CcSEcCtD
Perindopril—Malnutrition—Methotrexate—systemic scleroderma	2.87e-05	0.000336	CcSEcCtD
Perindopril—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	2.83e-05	0.000331	CcSEcCtD
Perindopril—Dysgeusia—Methotrexate—systemic scleroderma	2.81e-05	0.000329	CcSEcCtD
Perindopril—Nausea—Lisinopril—systemic scleroderma	2.81e-05	0.000328	CcSEcCtD
Perindopril—Anaphylactic shock—Prednisone—systemic scleroderma	2.81e-05	0.000328	CcSEcCtD
Perindopril—Oedema—Prednisone—systemic scleroderma	2.81e-05	0.000328	CcSEcCtD
Perindopril—Back pain—Methotrexate—systemic scleroderma	2.78e-05	0.000325	CcSEcCtD
Perindopril—Shock—Prednisone—systemic scleroderma	2.76e-05	0.000323	CcSEcCtD
Perindopril—Nervous system disorder—Prednisone—systemic scleroderma	2.75e-05	0.000322	CcSEcCtD
Perindopril—Tachycardia—Prednisone—systemic scleroderma	2.74e-05	0.00032	CcSEcCtD
Perindopril—Dizziness—Mycophenolate mofetil—systemic scleroderma	2.74e-05	0.00032	CcSEcCtD
Perindopril—Skin disorder—Prednisone—systemic scleroderma	2.72e-05	0.000319	CcSEcCtD
Perindopril—Hyperhidrosis—Prednisone—systemic scleroderma	2.71e-05	0.000317	CcSEcCtD
Perindopril—Anorexia—Prednisone—systemic scleroderma	2.67e-05	0.000313	CcSEcCtD
Perindopril—Ill-defined disorder—Methotrexate—systemic scleroderma	2.67e-05	0.000312	CcSEcCtD
Perindopril—Anaemia—Methotrexate—systemic scleroderma	2.65e-05	0.000311	CcSEcCtD
Perindopril—Vomiting—Mycophenolate mofetil—systemic scleroderma	2.63e-05	0.000308	CcSEcCtD
Perindopril—Rash—Mycophenolate mofetil—systemic scleroderma	2.61e-05	0.000305	CcSEcCtD
Perindopril—Dermatitis—Mycophenolate mofetil—systemic scleroderma	2.61e-05	0.000305	CcSEcCtD
Perindopril—Headache—Mycophenolate mofetil—systemic scleroderma	2.59e-05	0.000303	CcSEcCtD
Perindopril—Malaise—Methotrexate—systemic scleroderma	2.59e-05	0.000303	CcSEcCtD
Perindopril—Vertigo—Methotrexate—systemic scleroderma	2.58e-05	0.000302	CcSEcCtD
Perindopril—Leukopenia—Methotrexate—systemic scleroderma	2.57e-05	0.000301	CcSEcCtD
Perindopril—Musculoskeletal discomfort—Prednisone—systemic scleroderma	2.56e-05	0.000299	CcSEcCtD
Perindopril—Insomnia—Prednisone—systemic scleroderma	2.54e-05	0.000297	CcSEcCtD
Perindopril—Paraesthesia—Prednisone—systemic scleroderma	2.52e-05	0.000295	CcSEcCtD
Perindopril—Cough—Methotrexate—systemic scleroderma	2.51e-05	0.000293	CcSEcCtD
Perindopril—Dyspepsia—Prednisone—systemic scleroderma	2.47e-05	0.000289	CcSEcCtD
Perindopril—Nausea—Mycophenolate mofetil—systemic scleroderma	2.46e-05	0.000288	CcSEcCtD
Perindopril—Chest pain—Methotrexate—systemic scleroderma	2.45e-05	0.000286	CcSEcCtD
Perindopril—Myalgia—Methotrexate—systemic scleroderma	2.45e-05	0.000286	CcSEcCtD
Perindopril—Arthralgia—Methotrexate—systemic scleroderma	2.45e-05	0.000286	CcSEcCtD
Perindopril—Decreased appetite—Prednisone—systemic scleroderma	2.44e-05	0.000285	CcSEcCtD
Perindopril—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	2.43e-05	0.000284	CcSEcCtD
Perindopril—Fatigue—Prednisone—systemic scleroderma	2.42e-05	0.000283	CcSEcCtD
Perindopril—Discomfort—Methotrexate—systemic scleroderma	2.42e-05	0.000283	CcSEcCtD
Perindopril—Constipation—Prednisone—systemic scleroderma	2.4e-05	0.000281	CcSEcCtD
Perindopril—Confusional state—Methotrexate—systemic scleroderma	2.36e-05	0.000277	CcSEcCtD
Perindopril—Anaphylactic shock—Methotrexate—systemic scleroderma	2.34e-05	0.000274	CcSEcCtD
Perindopril—Feeling abnormal—Prednisone—systemic scleroderma	2.31e-05	0.00027	CcSEcCtD
Perindopril—Nervous system disorder—Methotrexate—systemic scleroderma	2.3e-05	0.000269	CcSEcCtD
Perindopril—Thrombocytopenia—Methotrexate—systemic scleroderma	2.3e-05	0.000269	CcSEcCtD
Perindopril—Gastrointestinal pain—Prednisone—systemic scleroderma	2.29e-05	0.000268	CcSEcCtD
Perindopril—Skin disorder—Methotrexate—systemic scleroderma	2.28e-05	0.000266	CcSEcCtD
Perindopril—Hyperhidrosis—Methotrexate—systemic scleroderma	2.27e-05	0.000265	CcSEcCtD
Perindopril—Anorexia—Methotrexate—systemic scleroderma	2.23e-05	0.000261	CcSEcCtD
Perindopril—Urticaria—Prednisone—systemic scleroderma	2.23e-05	0.000261	CcSEcCtD
Perindopril—Abdominal pain—Prednisone—systemic scleroderma	2.22e-05	0.000259	CcSEcCtD
Perindopril—Body temperature increased—Prednisone—systemic scleroderma	2.22e-05	0.000259	CcSEcCtD
Perindopril—Hypotension—Methotrexate—systemic scleroderma	2.19e-05	0.000256	CcSEcCtD
Perindopril—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	2.14e-05	0.00025	CcSEcCtD
Perindopril—Insomnia—Methotrexate—systemic scleroderma	2.12e-05	0.000248	CcSEcCtD
Perindopril—Paraesthesia—Methotrexate—systemic scleroderma	2.11e-05	0.000246	CcSEcCtD
Perindopril—Dyspnoea—Methotrexate—systemic scleroderma	2.09e-05	0.000245	CcSEcCtD
Perindopril—Somnolence—Methotrexate—systemic scleroderma	2.08e-05	0.000244	CcSEcCtD
Perindopril—Dyspepsia—Methotrexate—systemic scleroderma	2.06e-05	0.000241	CcSEcCtD
Perindopril—Decreased appetite—Methotrexate—systemic scleroderma	2.04e-05	0.000238	CcSEcCtD
Perindopril—Gastrointestinal disorder—Methotrexate—systemic scleroderma	2.02e-05	0.000237	CcSEcCtD
Perindopril—Fatigue—Methotrexate—systemic scleroderma	2.02e-05	0.000236	CcSEcCtD
Perindopril—Asthenia—Prednisone—systemic scleroderma	2.01e-05	0.000235	CcSEcCtD
Perindopril—Pain—Methotrexate—systemic scleroderma	2e-05	0.000235	CcSEcCtD
Perindopril—Pruritus—Prednisone—systemic scleroderma	1.98e-05	0.000232	CcSEcCtD
Perindopril—Feeling abnormal—Methotrexate—systemic scleroderma	1.93e-05	0.000226	CcSEcCtD
Perindopril—Diarrhoea—Prednisone—systemic scleroderma	1.92e-05	0.000225	CcSEcCtD
Perindopril—Gastrointestinal pain—Methotrexate—systemic scleroderma	1.92e-05	0.000224	CcSEcCtD
Perindopril—Urticaria—Methotrexate—systemic scleroderma	1.86e-05	0.000218	CcSEcCtD
Perindopril—Dizziness—Prednisone—systemic scleroderma	1.85e-05	0.000217	CcSEcCtD
Perindopril—Abdominal pain—Methotrexate—systemic scleroderma	1.85e-05	0.000217	CcSEcCtD
Perindopril—Body temperature increased—Methotrexate—systemic scleroderma	1.85e-05	0.000217	CcSEcCtD
Perindopril—Vomiting—Prednisone—systemic scleroderma	1.78e-05	0.000209	CcSEcCtD
Perindopril—Rash—Prednisone—systemic scleroderma	1.77e-05	0.000207	CcSEcCtD
Perindopril—Dermatitis—Prednisone—systemic scleroderma	1.77e-05	0.000207	CcSEcCtD
Perindopril—Headache—Prednisone—systemic scleroderma	1.76e-05	0.000206	CcSEcCtD
Perindopril—Asthenia—Methotrexate—systemic scleroderma	1.68e-05	0.000197	CcSEcCtD
Perindopril—Nausea—Prednisone—systemic scleroderma	1.67e-05	0.000195	CcSEcCtD
Perindopril—Pruritus—Methotrexate—systemic scleroderma	1.66e-05	0.000194	CcSEcCtD
Perindopril—Diarrhoea—Methotrexate—systemic scleroderma	1.6e-05	0.000188	CcSEcCtD
Perindopril—Dizziness—Methotrexate—systemic scleroderma	1.55e-05	0.000181	CcSEcCtD
Perindopril—Vomiting—Methotrexate—systemic scleroderma	1.49e-05	0.000174	CcSEcCtD
Perindopril—Rash—Methotrexate—systemic scleroderma	1.48e-05	0.000173	CcSEcCtD
Perindopril—Dermatitis—Methotrexate—systemic scleroderma	1.48e-05	0.000173	CcSEcCtD
Perindopril—Headache—Methotrexate—systemic scleroderma	1.47e-05	0.000172	CcSEcCtD
Perindopril—Nausea—Methotrexate—systemic scleroderma	1.39e-05	0.000163	CcSEcCtD
